Recombinant Human GPD1 /GPDH-C Protein (rh GPD1 /GPDH) Met 1 - Met 349 (Accession # AAH32234) was produced in E.coli cells at ACROBiosystems.
rh GPD1 /GPDH is fused with a polyhistidine tag at the N-terminus, and has a calculated MW of 38.4 kDa. The predicted N-terminus is Met. DTT-reduced Protein migrates as 34 kDa in SDS-PAGE .
Less than 1.0 EU per μg of the rh GPD1 /GPDH by the LAL method.
>95% as determined by SDS-PAGE.
Lyophilized from 0.22 μm filtered solution in 50 mM Tris,150 mM NaCl,pH8.0. Normally Mannitol or Trehalose are added as protectants before lyophilization.
Contact us for customized product form or formulation.
See Certificate of Analysis for reconstitution instructions and specific concentrations.
Avoid repeated freeze-thaw cycles.
No activity loss was observed after storage at:
In lyophilized state for 1 year (4oC); After reconstitution under sterile conditions for 3 months (-70oC).
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic (GPD1), a member of the NAD-dependent glycerol-3-phosphate dehydrogenase family, is also known as GPD-C or GPDH-C. The function of GPD1 is inhibited by zinc ions and sulfate. GPD1 can also interact selectively and non-covalently with nicotinamide adenine dinucleotide (NAD), a coenzyme involved in many redox and biosynthetic reactions; binding may be to either the oxidized form, NAD+, or the reduced form, NADH. Mutations in GPD1 gene are a cause of Hypertriglyceridemia, transient infantile (HTGIT).
Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.